Mouse T-lymphocyte surface antigens

Mouse T-lymphocyte surface antigens refer to a heterogeneous collection of proteins expressed on the plasma membrane of murine T-cells, including CD3, CD4, CD8, and Thy-1 (CD90). These molecules are fundamental to the immune system, mediating antigen recognition, T-cell maturation, and signal transduction (Janeway et al., Immunobiology, 2001; UniProt). In pharmacological contexts, these antigens are collectively targeted by polyclonal preparations such as anti-thymocyte globulin (ATG) to induce rapid and potent immunosuppression (DrugBank, DB00033). The therapeutic effect is achieved through the depletion of T-lymphocytes via complement-mediated lysis and apoptosis, as well as the functional interference with receptors necessary for immune activation (Mohty, Leukemia, 2007). This target group is extensively studied in murine models of organ transplantation, graft-versus-host disease, and various autoimmune pathologies to evaluate immunosuppressive strategies (PubMed, PMID: 17301823). However, targeting these antigens carries risks such as cytokine release syndrome and increased susceptibility to infections due to profound lymphopenia (StatPearls, Antithymocyte Globulin).

Other names

Murine T-cell surface markersT-lymphocyte antigensCD antigensThymocyte antigens

The primary mechanism involves the binding of antibodies to various T-cell surface antigens, leading to cell depletion through complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity (ADCC). Additionally, these interactions can cause the internalization or masking of essential signaling receptors (like the TCR/CD3 complex), thereby inhibiting T-cell activation, proliferation, and cytokine production (Mohty, Leukemia, 2007; PubMed, PMID: 17301823).